Cell-mediated Immune Response to Human Papillomavirus Infection

Overview

Journal Clin Diagn Lab Immunol

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2001 Mar 10

PMID 11238198

Citations 96

Authors

M Scott

M Nakagawa

A B Moscicki

Affiliations

Soon will be listed here.

Citing Articles

A Prospective, Non-interventional Observational Study to Assess the Efficacy, Safety, and Tolerability of the Casein Hydrolysate-Based Food Supplement in High-Risk Human Papillomavirus-Positive Women.

Pingarron C, Duque A, Lopez A, Ferragud J Cureus. 2025; 17(3):e80201.

PMID: 40061851 PMC: 11887413. DOI: 10.7759/cureus.80201.

Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers.

Woo S, Park P, An T, Fatima M, Moon Y, Lee S Hum Vaccin Immunother. 2025; 21(1):2457187.

PMID: 39957237 PMC: 11834422. DOI: 10.1080/21645515.2025.2457187.

Impact of HIV on HPV-related cancers in men who have sex with men: a review.

Zhang Z, Xing Y, Gong T, Li W, Zhang S, Wei L Front Cell Infect Microbiol. 2025; 14:1428491.

PMID: 39902182 PMC: 11788171. DOI: 10.3389/fcimb.2024.1428491.

Prevalence of HPV in anal cancer: exploring the role of infection and inflammation.

Ebrahimi F, Rasizadeh R, Jafari S, Baghi H Infect Agent Cancer. 2024; 19(1):63.

PMID: 39696546 PMC: 11654204. DOI: 10.1186/s13027-024-00624-0.

Monocyte and Macrophage Functions in Oncogenic Viral Infections.

Echevarria-Lima J, Moles R Viruses. 2024; 16(10).

PMID: 39459945 PMC: 11512331. DOI: 10.3390/v16101612.

References

Luxton J, Rose R, Coletart T, Wilson P, Shepherd P . Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls. J Gen Virol. 1997; 78 ( Pt 4):917-23. DOI: 10.1099/0022-1317-78-4-917. View

Dupuy C, Buzoni-Gatel D, Touze A, Le Cann P, Bout D, Coursaget P . Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles. Microb Pathog. 1997; 22(4):219-25. DOI: 10.1006/mpat.1996.0113. View

Prussin C . Cytokine flow cytometry: understanding cytokine biology at the single-cell level. J Clin Immunol. 1997; 17(3):195-204. DOI: 10.1023/a:1027350226435. View

Evans E, Man S, Evans A, Borysiewicz L . Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res. 1997; 57(14):2943-50. View

Kadish A, Ho G, Burk R, Wang Y, ROMNEY S, Ledwidge R . Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst. 1997; 89(17):1285-93. DOI: 10.1093/jnci/89.17.1285. View

Palefsky J, Holly E, Ralston M, Arthur S, Hogeboom C, Darragh T . Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Genitourin Med. 1997; 73(3):174-80. PMC: 1195816. DOI: 10.1136/sti.73.3.174. View

Malejczyk M, Jozwiak J, Osiecka A, Roszkowski P, Rogozinski T, Walczak L . Serum levels of soluble tumor-necrosis-factor receptors in patients with benign and malignant HPV-associated anogenital lesions. Int J Cancer. 1997; 73(1):16-9. DOI: 10.1002/(sici)1097-0215(19970926)73:1<16::aid-ijc3>3.0.co;2-4. View

Bontkes H, de Gruijl T, Walboomers J, van den Muysenberg A, Gunther A, Scheper R . Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions. Br J Cancer. 1997; 76(10):1353-60. PMC: 2228142. DOI: 10.1038/bjc.1997.560. View

Norris D . Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. J Invest Dermatol. 1990; 95(6 Suppl):111S-120S. DOI: 10.1111/1523-1747.ep12874977. View

10.

Scheffner M, Werness B, Huibregtse J, Levine A, Howley P . The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990; 63(6):1129-36. DOI: 10.1016/0092-8674(90)90409-8. View

11.

Barker J, Mitra R, Griffiths C, Dixit V, Nickoloff B . Keratinocytes as initiators of inflammation. Lancet. 1991; 337(8735):211-4. DOI: 10.1016/0140-6736(91)92168-2. View

12.

Chen L, Thomas E, Hu S, Hellstrom I, Hellstrom K . Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci U S A. 1991; 88(1):110-4. PMC: 50759. DOI: 10.1073/pnas.88.1.110. View

13.

Greenberg P . Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol. 1991; 49:281-355. DOI: 10.1016/s0065-2776(08)60778-6. View

14.

Noelle R, Snow E . T helper cell-dependent B cell activation. FASEB J. 1991; 5(13):2770-6. DOI: 10.1096/fasebj.5.13.1833257. View

15.

Salgame P, Abrams J, Clayberger C, Goldstein H, Convit J, Modlin R . Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 1991; 254(5029):279-82. DOI: 10.1126/science.254.5029.279. View

16.

Woodworth C, Lichti U, Simpson S, Evans C, DIPAOLO J . Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells. Cancer Res. 1992; 52(2):456-63. View

17.

Chen L, Mizuno M, Singhal M, Hu S, Galloway D, Hellstrom I . Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16. J Immunol. 1992; 148(8):2617-21. View

18.

Konno R, Sato S, Yajima A . Progression of squamous cell carcinoma of the uterine cervix from cervical intraepithelial neoplasia infected with human papillomavirus: a retrospective follow-up study by in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol. 1992; 11(2):105-12. DOI: 10.1097/00004347-199204000-00004. View

19.

Critchlow C, Holmes K, Wood R, Krueger L, Dunphy C, Vernon D . Association of human immunodeficiency virus and anal human papillomavirus infection among homosexual men. Arch Intern Med. 1992; 152(8):1673-6. View

20.

Koutsky L, Holmes K, Critchlow C, Stevens C, Paavonen J, Beckmann A . A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992; 327(18):1272-8. DOI: 10.1056/NEJM199210293271804. View